leucine and Minimal Disease, Residual

leucine has been researched along with Minimal Disease, Residual in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agliano, A; Bertolini, F; Bleau, AM; Calvo, A; Colombo, F; Larzabal, L; Marighetti, P; Martin-Padura, I; Prior, C; Redrado, M	1

Other Studies

1 other study(ies) available for leucine and Minimal Disease, Residual

Article	Year
Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts. Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:7 Topics: Administration, Metronomic; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; CD13 Antigens; Cell Line, Tumor; Cyclophosphamide; Drug Synergism; Humans; Leucine; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasm, Residual; Neoplastic Stem Cells; Spheroids, Cellular; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2012

Article

Year

Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts.

Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:7

Topics: Administration, Metronomic; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; CD13 Antigens; Cell Line, Tumor; Cyclophosphamide; Drug Synergism; Humans; Leucine; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasm, Residual; Neoplastic Stem Cells; Spheroids, Cellular; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2012